Sutro Biopharma's market cap is currently $150.90M. The company's EPS TTM is $-1.623; its P/E ratio is ―; Sutro Biopharma is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 153.73M	$ 67.77M	$ 61.88M	$ 42.72M	$ 42.74M
Gross Profit	$ 146.91M	$ 59.48M	$ 52.11M	$ -34.24M	$ -22.88M
Operating Income	$ -89.28M	$ -128.94M	$ -98.52M	$ -71.06M	$ -55.47M
EBITDA	$ -67.92M	$ -105.07M	$ -98.52M	$ -23.75M	$ -46.62M
Net Income	$ -106.79M	$ -119.20M	$ -108.67M	$ -36.20M	$ -55.74M
Balance Sheet
Cash & Short-Term Investments	$ 375.62M	$ 302.34M	$ 197.94M	$ 368.14M	$ 117.86M
Total Assets	$ 470.74M	$ 406.94M	$ 341.41M	$ 394.11M	$ 156.37M
Total Debt	$ 33.63M	$ 67.52M	$ 57.37M	$ 24.55M	$ 9.88M
Net Debt	$ -35.63M	$ 20.26M	$ 26.96M	$ -181.61M	$ 4.92M
Total Liabilities	$ 321.09M	$ 189.90M	$ 88.84M	$ 62.06M	$ 58.58M
Stockholders' Equity	$ 149.65M	$ 217.05M	$ 252.56M	$ 332.05M	$ 97.79M
Cash Flow
Free Cash Flow	$ -115.93M	$ -4.31M	$ -97.00M	$ -74.93M	$ -68.50M
Operating Cash Flow	$ -111.62M	$ 3.55M	$ -81.68M	$ -67.80M	$ -65.02M
Investing Cash Flow	$ -3.92M	$ -35.02M	$ -97.31M	$ 604.00K	$ -51.13M
Financing Cash Flow	$ 137.55M	$ 48.31M	$ 3.26M	$ 269.25M	$ -4.18M

Currency in USD

Sutro Biopharma Earnings and Revenue History

Income Statement >

Sutro Biopharma Debt to Assets

Balance Sheet >

Sutro Biopharma Cash Flow

Cash Flow >

Sutro Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing